American Society of Clinical Oncology

MTEM Stock Price - Molecular Templates Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch

10-Q: MOLECULAR TEMPLATES, INC.<p>10-Q: MOLECULAR TEMPLATES, INC.<p>Aug. 9, 2018 at 5:03 p.m. ET<br>• on Edgar Online - (EDG = 10Q, 10K)<p>A High-Throughput Screen …

Atoms

Top Cancer Researcher José Baselga Fails to Disclose Corporate Financial Ties in Major Research Journals — ProPublica

This article was produced in partnership with The New York Times.<p>One of the world’s top breast cancer doctors failed to disclose millions of dollars …

Cancer

Navigating Aging | Kaiser Health News

By <b>Judith Graham</b> September 6, 2018<p>Is there anything families can do to fight these evictions?<p>By <b>Judith Graham</b> August 23, 2018<p>More and more older …

Health Care

Here's Why Nektar Therapeutics Jumped 26.4% in August

Investors are regaining their confidence in the high-flying oncology company.<p>What happened<p>Shares of <b>Nektar Therapeutics</b> (NASDAQ:NKTR) rose 26.4% in …

Investing

20 New Alexandria Jobs: Program Engineer, Special Ed Teacher

Companies like Center For Autism and Related Disorders and American Academy of PAs have new job listings around Alexandria.<p>ALEXANDRIA, VA—As you send …

American Red Cross

20 New Del Ray Jobs: Art Instructor, Social Worker

Companies like Center For Autism and Related Disorders and American Red Cross have new job listings around Del Ray.<p>ALEXANDRIA, VA—As you send the …

American Red Cross

Immunohistochemical analysis of estrogen receptor in breast cancer with <i>ESR1</i> mutations detected by hybrid capture-based next-generation sequencing

1.<p>Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting …

Cancer

Alcohol is a leading cause of death, disease worldwide, study says

CLOSE<p>A new study reveals that the safe amount of alcohol to drink is probably less than you would imagine. Tony Spitz has the details.<p>Alcohol is …

Montana

Amgen Files for Once-Weekly Regimen for Myeloma Drug Kyprolis

1 / 2<p>Amgen (AMGN) submits a supplemental new drug application to the FDA, seeking an approval for once-weekly dosage of its multiple myeloma drug, …

Amgen

AbbVie, Johnson & Johnson grab another Imbruvica nod with early OK in rare blood cancer

Two months ahead of the FDA decision date, the agency approved AbbVie and J&J's Imbruvica, plus Roche's Rituxan, to treat adults with a rare blood …

Blood Cancer

Alcohol is a leading cause of death, disease worldwide: study

Alcohol is killing more people globally than we originally thought, according to a new study.<p>The study, published Thursday in the peer-reviewed …

University of Washington

Drug Combo Fights Melanoma That Has Spread to Brain

THURSDAY, Aug. 23, 2018 (HealthDay News) -- A combination of two drugs that work with the immune system can help beat back melanoma that has moved to …

Cancer

IO Data Changing Standard Care in Locally Advanced Lung Cancers

Hello. This is Mark Kris from Memorial Sloan Kettering, and I'm speaking today about the use of immune checkpoint blockade in the treatment of …

Cancer

Insuring patient access and affordability for treatments for rare and ultrarare diseases: a policy statement of the American College of Medical Genetics and Genomics

1.<p>Thomas K. Costly drug for fatal muscular disease wins F.D.A. approval <i>New York Times</i>. 2016 Dec 30.<p>2.<p>IMS Institute for Healthcare Informatics. …

Genetics

NICE stands firm on 'no' vote for Roche's Perjeta in postsurgery breast cancer

Back in June, England’s cost watchdog refused to recommend Roche’s Perjeta for postsurgery breast cancer patients. And it’s sticking by that decision.<p>…

Breast Cancer

FDA Approves Lenvatinib (Lenvima) for Liver Cancer

The US Food and Drug Administration (FDA) has approved lenvatinib capsules (<i>Lenvima</i>, Eisai) for first-line treatment of patients with unresectable …

Medicine

It’s Early Days for the Use of AI in Medicine

We know that AI can make a big difference in solving medical challenges, and we see an enormous business opportunity.<p>We disagree with your suggestion in “IBM Has a Watson Dilemma” (Exchange, Aug. 11) that IBM has not made enough progress on bringing the benefits of artificial intelligence to health …

Health Care

Medical director of oncology no longer employed by CHI hospital in Grand Island

Grand Island — Dr. Mehmet Sitki Copur, a longtime Grand Island leader in the fight against cancer, is no longer employed by CHI Health St. Francis.<p>A …

Cancer

Discovery of new susceptibility genes: proceed cautiously

1.<p>Fishbein L. Pheochromocytoma and paraganglioma: genetics, diagnosis, and treatment. <i>Hematol Oncol Clin North Am</i>. 2016;30:135–150.<p>2.<p>Robson ME, Storm …

Genetics

Immunotherapy for Kidney Cancer | Renal Cell Carcinoma Immunotherapy | CNN

What to Expect With Immunotherapy for Renal Cell Carcinoma<p>Ashley Festa<p>Was this helpful?<p>x<p>This content is created or selected by the Healthgrades editorial team and is funded by an advertising sponsor. The content is subject to the Healthgrades medical review process for accuracy, balance and …

Cancer

Want Strong US Cancer Research? Use This Social Media Kit

The American Society of Clinical Oncology (ASCO) has launched "I Live to Conquer Cancer," a social media–driven, interactive campaign to rally …

Social Media

Immunotherapy Complete Responses Suggest Metastatic Melanoma Cures

This is Dr Jeffrey Weber. I am a medical oncologist at the Laura and Isaac Perlmutter Cancer Center at New York University Langone Health in New York …

Medicine

The Genetics and Genomics of Melanoma

Pauline Funchain, MD, associate staff in Cleveland Clinic Cancer Center, specializes in the medical oncology of melanoma, head and neck cancer, …

Cancer

bluebird bio Prepares Its "Transition to a Commercial Company"

The biotech expects to file a marketing application with EU regulators by the end of the year.<p>As this development-stage drugmaker typically does,</b> …

Investing

ImmunoGen's Investors Play the Waiting Game

Crucial data is expected in the first half of next year.<p>With the Forward I clinical trial testing mirvetuximab as a monotherapy in platinum-resistant …

Investing

Physician Profiles 2018: John W. McBroom, MD, FACS, FACOG

Dr. John W. McBroom, a Castle Connolly “Top Doctor” every year since 2013, is a board-certified gynecologic oncologist, a certified member of the MD …

Cancer

Ivosidenib earns FDA approval against IDH1+ acute myeloid leukemia

Clinical trials at University of Colorado Cancer Center and elsewhere now result in the drug ivosidenib earning approval from the U.S. Food and Drug …

Myeloid Leukemia

Want to reach smartphone-happy doctors? Hint: Typical mobile marketing won't work

Physicians are people too—carrying phones and looking up information multiple times a day just like everyone else. Almost 80% of doctors use mobile …

Pharma

IBM's Watson reportedly created unsafe cancer treatment plans

Medical experts apparently found multiple instances of unsafe recommendations by the system.<p>Last year, studies presented at the American Society of Clinical Oncology's annual meeting showed that IBM Watson was pretty darn good at creating treatment plans for cancer patients. Turns out, however, …

Technology

Some Cancer Treatment Recommendations From IBM's Watson Were Unsafe, Report Finds

IBM’s Watson could need a little more time in medical school, if a new report is accurate.<p>Documents reviewed by <i>Stat</i>, a medical news site, show the …

Artificial Intelligence